TCGA data of the entire PAAD (pancreatic adenocarcinoma) cohort showed SIAH3 expression to be decreased in advanced cancer stages (p < 0.01, Figure 4A), suggesting a possible correlation with disease progression. Here, SIAH3 is linked to pancreatic adenocarcinoma.